USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/28765
Title: The use of magnesium salts in the therapy of arterial hypertension
Authors: Nicolăescu Maria
Issue Date: 2024
Publisher: Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova
Citation: Nicolăescu Maria. The use of magnesium salts in the therapy of arterial hypertension. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 358. ISBN 978-9975-3544-2-4.
Abstract: Introduction. Annually, more than 10 million lives are lost due to high blood pressure (HT). A low magnesium content in drinking water leads to increased risk of developing cardiovascular disease (especially coronary heart disease) and sudden death. Magnesium (Mg2+ ) plays a direct role in the functioning of the endothelial system, controls the contraction-relaxation processes of smooth muscle cells, affects the mechanisms of vascular wall calcification, the coagulation system, systemic inflammation, as well as the conduction system of the heart. Aim of study. The research aims to analyze the bibliographic data regarding the benefits of Mg2+ salts in HT therapy. Methods and materials. To carry out the study, 21 scientific articles were researched using the following databases: PubMed, MEDLINE, SciSearch, The Thomson Corporation and Cochrane Electronic Library, Google Academic. Results. Mg2+ deficiency has been shown to correlate with a number of chronic cardiovascular diseases, including HT, diabetes mellitus, and hyperlipidemia in many studies. Unfortunately, it is impossible to ensure such an increased intake of Mg2+ only by changing the diet. For the longterm treatment of hypomagnesemia, drugs containing Mg2+ are used: tablets or oral solution. Thus, the drugs, containing inorganic salts of Mg2+, have absorption of no more than 5%, therefore, to increase bioavailability, Mg2+-salts are used in combination with vit.B6, with potassium and organic ones: aspartic acid, lactic acid, glutamic acid, citric acid, orotic acid. In case of Mg2+ deficiency, its additional administration is necessary (10-30 mg/kg per day). Depending on the clinical situation, 25% magnesium sulfate injection is given intravenously slowly in the health-care setting. Conclusion. Magnesium is an essential electrolyte for living organisms. Magnesium has vasodilatory, anti-inflammatory, anti-ischemic and antiarrhythmic properties. Mg2+ supplementation may help reduce cardiovascular risk factors associated with HT caused by Mg2+ deficiency due to chronic diuretic use, inadequate intake, or both. low magnesium content in drinking water leads to increased r isk of developing cardiovascular disease (especially coronary heart disease) and sudden deat h. Magnesium (Mg2+ ) plays a direct role in the functioning of the endothelial system, control s the contraction-relaxation processes of smooth muscle cells, affects the mechanisms of vascula r wall calcification, the coagulation system, systemic inflammation, as well as the conduction system of the heart. Aim of study. The research aims to analyze the bibliographic data regardi ng the benefits of Mg2+ salts in HT therapy. Methods and materials. To carry out the study, 21 scientific articles were res earched using the following databases: PubMed, MEDLINE, SciSearch, The Thomso n Corporation and Cochrane Electronic Library, Google Academic. Results. Mg2+ deficiency has been shown to correlate with a number of chronic cardiovascular diseases, including HT, diabetes mellitus, and hyperlipidemia i n many studies. Unfortunately, it is impossible to ensure such an increased intake of Mg2+ only by c hanging the diet. For the longterm treatment of hypomagnesemia, drugs containing Mg2+ are use d: tablets or oral solution. Thus, the drugs, containing inorganic salts of Mg2+, have absor ption of no more than 5%, therefore, to increase bioavailability, Mg2+-salts are used in combination with vit.B6, with potassium and organic ones: aspartic acid, lactic acid, gluta mic acid, citric acid, orotic acid. In case of Mg2+ deficiency, its additional administration is neces sary (10-30 mg/kg per day). Depending on the clinical situation, 25% magnesium sulfate inject ion is given intravenously slowly in the health-care setting. Conclusion. Magnesium is an essential electrolyte for living organi sms. Magnesium has vasodilatory, anti-inflammatory, anti-ischemic and antia rrhythmic properties. Mg2+ supplementation may help reduce cardiovascular risk facto rs associated with HT caused by Mg2+ deficiency due to chronic diuretic use, inadequate intake, or both.
metadata.dc.relation.ispartof: MedEspera 2024
URI: https://ibn.idsi.md/collection_view/3104
http://repository.usmf.md/handle/20.500.12710/28765
ISBN: 978-9975-3544-2-4
Appears in Collections:MedEspera 2024

Files in This Item:
File Description SizeFormat 
MEsp24_358.pdf348.08 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback